Olivera PA - Search Results

1

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. Olivera PA, et al. Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):857-873. doi: 10.1038/s41575-021-00492-8. Epub 2021 Aug 27. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34453143 Free PMC article.

2

Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation.

Qaiyum Z, Tang M, Olivera PA, Inman RD. Qaiyum Z, et al. Among authors: olivera pa. J Rheumatol. 2023 Aug;50(8):1090-1092. doi: 10.3899/jrheum.2022-1272. Epub 2023 May 15. J Rheumatol. 2023. PMID: 37188381 No abstract available.

3

Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review.

Martelli L, Olivera P, Roblin X, Attar A, Peyrin-Biroulet L. Martelli L, et al. J Gastroenterol. 2017 Jan;52(1):19-25. doi: 10.1007/s00535-016-1266-1. Epub 2016 Sep 24. J Gastroenterol. 2017. PMID: 27665099 Review.

4

Next generation of small molecules in inflammatory bowel disease.

Olivera P, Danese S, Peyrin-Biroulet L. Olivera P, et al. Gut. 2017 Feb;66(2):199-209. doi: 10.1136/gutjnl-2016-312912. Epub 2016 Nov 17. Gut. 2017. PMID: 27856614 No abstract available.

5

JAK inhibition in inflammatory bowel disease.

Olivera P, Danese S, Peyrin-Biroulet L. Olivera P, et al. Expert Rev Clin Immunol. 2017 Jul;13(7):693-703. doi: 10.1080/1744666X.2017.1291342. Epub 2017 Feb 17. Expert Rev Clin Immunol. 2017. PMID: 28164724 Review.

6

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.

Allen PB, Olivera P, Emery P, Moulin D, Jouzeau JY, Netter P, Danese S, Feagan B, Sandborn WJ, Peyrin-Biroulet L. Allen PB, et al. Aliment Pharmacol Ther. 2017 Apr;45(8):1058-1072. doi: 10.1111/apt.13995. Epub 2017 Mar 1. Aliment Pharmacol Ther. 2017. PMID: 28247573 Review.

7

Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience.

Olivera P, Thiriet L, Luc A, Baumann C, Danese S, Peyrin-Biroulet L. Olivera P, et al. Inflamm Bowel Dis. 2017 Jun;23(6):976-985. doi: 10.1097/MIB.0000000000001072. Inflamm Bowel Dis. 2017. PMID: 28333755

8

Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal.

Dirrenberger B, Clerc-Urmès I, Germain A, Bresler L, Olivera P, Martelli L, Danese S, Baumann C, Laurent V, Peyrin-Biroulet L. Dirrenberger B, et al. Dig Liver Dis. 2017 Aug;49(8):864-871. doi: 10.1016/j.dld.2017.03.028. Epub 2017 Apr 11. Dig Liver Dis. 2017. PMID: 28454853

9

Surgical rates in the era of biological therapy: up, down or unchanged?

Olivera P, Spinelli A, Gower-Rousseau C, Danese S, Peyrin-Biroulet L. Olivera P, et al. Curr Opin Gastroenterol. 2017 Jul;33(4):246-253. doi: 10.1097/MOG.0000000000000361. Curr Opin Gastroenterol. 2017. PMID: 28463854 Review.

10

Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.

Olivera P, Sandborn WJ, Panés J, Baumann C, D'Haens G, Vermeire S, Danese S, Peyrin-Biroulet L. Olivera P, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):773-783. doi: 10.1111/apt.14514. Epub 2018 Jan 19. Aliment Pharmacol Ther. 2018. PMID: 29349829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters